์ธํํฐ์คํผ ๊ฒฐ์ ์ ๋ฆฌ์ฐ
์ธํํฐ์คํผ ๊ฒฐ์ ์ ๋ฆฌ์ฐ(CCFA)์ ์ง์์ฑ ์์ํ ์ ์ฉ **3์ธ๋ ์ธํ๋ก์คํฌ๋ฆฐ**์ ๋๋ค. ๋ฉด์ค์ ๊ธฐ๋ฐ์ผ๋ก ์ ์กฐ๋์ด 1ํ ์ฃผ์ฌ๋ก ์์ผ๊ฐ ์๋ฐฉํ ํจ๊ณผ๋ฅผ ์ ๊ณตํฉ๋๋ค. - **๊ด๋ฒ์ ํญ๊ท ํ์ฑ:** ์ฃผ์ ๊ทธ๋ ์์ฑ ๋ฐ ์์ฑ ํธํก๊ธฐ ๋ณ์์ฒด์ ๋ํด ๋์ ํจ๋ฅ์ ๋ํ๋ ๋๋ค. - **๋์ ๋๋ฌผ:** ์(์ ํธํก๊ธฐ ์งํ ๋ฐ ์ง๊ฐ๋ถ๋), ๋ผ์ง(๋ผ์ง ํธํก๊ธฐ ์งํ) ๋ฐ ๋ง(๋๋ฌผ์ฑ ์ฐ์์๊ตฌ๊ท ์ ์ํ ํ๊ธฐ๋ ๊ฐ์ผ)์ ์ฌ์ฉํ๋๋ก FDA ์น์ธ์ ๋ฐ์์ต๋๋ค. - **์์์ ์ฅ์ :** 1ํ ํฌ์ฌ(์/๋ผ์ง) ๋๋ 2ํ ํฌ์ฌ(๋ง)๋ก ์ ์ฒด ์น๋ฃ ๊ณผ์ ์ ์๋ฃํ ์ ์์ด ์์๋๋ฅผ ๋์ด๊ณ ๋๋ฌผ์ ์คํธ๋ ์ค๋ฅผ ์ค์ฌ์ค๋๋ค.
์์ฉ ๊ธฐ์ : Like other beta-lactam antibiotics, ceftiofur is a **time-dependent, bactericidal** agent. - It binds to **penicillin-binding proteins (PBPs)** โ inhibits peptidoglycan cross-linking โ disrupts bacterial cell wall synthesis โ activates autolysins โ cell lysis and death. - After administration, the parent compound is rapidly cleaved into furoic acid and **desfuroylceftiofur** (the primary active metabolite). - Desfuroylceftiofur is equally potent to the parent drug and exhibits a spectrum of activity similar to cefotaxime. High protein binding creates a 'reservoir effect' to maintain active drug levels at the site of infection.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- BRD treatment (Beef and lactating cattle) ยท 3 mg per lb (6.6 mg ceftiofur equivalents per kg) body weight (1.5 mL sterile suspension per 100 lb body weight) ยท SC ยท Single dose ยท Single dose ยท Administer as a single SC injection in the posterior aspect of the ear where it attaches to the head at the base of the ear (BOE).
- BRD treatment (Beef and non-lactating dairy cattle) ยท 6.6 mg ceftiofur equivalents/kg body weight (1.5 mL sterile suspension per 100 lb body weight) ยท SC ยท Single dose ยท Single dose ยท Administer as a single SC injection in the middle third of the posterior aspect of the ear.
- BRD control (Beef and non-lactating dairy cattle) ยท 6.6 mg ceftiofur equivalents (CE)/kg body weight (1.5 mL sterile suspension per 100 lb body weight) ยท SC ยท Single dose ยท Single dose ยท Administer as a SC injection either in the middle third of the posterior aspect of the ear or at the base of the ear.
- Lower respiratory tract infections caused by susceptible strains of Streptococcus equi ssp. zooepidemicus ยท 6.6 mg/kg IM; repeat in 4 days ยท IM ยท repeat in 4 days ยท 2 doses total ยท A maximum of 20 mL per injection site may be administered. Shake well before using.
- Swine respiratory disease (SRD) ยท 2.27 mg ceftiofur equivalents (CE) per lb (5 mg CE/kg) body weight ยท IM ยท Single dose ยท Single dose ยท Administer in the post-auricular region of the neck. No more than 2 mL should be injected in a single injection site. Pigs heavier than 88 lb (40 kg) will require more than one injection.
์ฉ๋์ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์ฐธ๊ณ ์๋ฃ์ ๋๋ค. ํญ์ ์ต์ ๋ผ๋ฒจ๊ณผ ๊ฐ๋ณ ํ์์ ๋ํด ํ์ธํ์ญ์์ค.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Patients with a history of hypersensitivity to cephalosporins
- Use with caution in patients with documented hypersensitivity to other beta-lactams (penicillins, carbapenems)
- Do not use in pre-ruminating calves to be processed for veal
์ด์๋ฐ์
- Hypersensitivity reactions (rashes, fever, eosinophilia, anaphylaxis)
- Granulocytopenia and thrombocytopenia (rare)
- Diarrhea, soft or loose stools (especially in horses)
- Injection site reactions: swelling, thickening, aseptic cellular infiltrate, discoloration
- Sudden death in cattle if injected into ear arteries
์ฝ๋ฌผ ์ํธ์์ฉ
- Aminoglycosides / Nephrotoxic drugs ยท Potential additive nephrotoxicity. Do not mix in the same syringe or IV line.
- Probenecid ยท Competitively blocks the tubular secretion of most cephalosporins, thereby increasing serum levels and serum half-lives.
๋ชจ๋ํฐ๋ง
- Clinical efficacy (resolution of respiratory signs within 3-5 days)
- Injection site reactions (swelling, inflammation)
- Fecal consistency (monitor for diarrhea, especially in horses)
- CBC (if used off-label in small animals)
- Renal function in patients with pre-existing renal compromise
๊ณผ์ฉ๋
Cephalosporin overdoses are unlikely to cause significant systemic toxicity other than **gastrointestinal distress** and potential injection site reactions. > **Regulatory Warning:** Use of dosages in excess of labeled recommendations (e.g., >6.6 mg/kg in cattle or >5 mg/kg in swine) or administration by unapproved routes (e.g., SC in the neck or IM in cattle) will likely cause **violative tissue residues**. Contact FARAD for assistance in determining appropriate extended withdrawal times if an overdose occurs.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.